Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Johnson & Johnson (JNJ) had Consolidated Net Income/Loss of $26.80B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$94.19B |
|
$26.80B |
|
$30.26B |
|
$63.94B |
|
$61.61B |
|
$32.58B |
|
-- |
|
$32.58B |
|
$32.58B |
|
$26.80B |
|
$26.80B |
|
|
Consolidated Net Income/Loss |
$26.80B |
$26.80B |
|
$32.67B |
|
$32.67B |
|
-- |
|
2.43B |
|
-- |
|
$11.03 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|